543.79MMarket Cap-3352P/E (TTM)
4.860High4.605Low622.61KVolume4.630Open4.530Pre Close2.97MTurnover0.66%Turnover RatioLossP/E (Static)114.24MShares9.39052wk High-31.73P/B450.99MFloat Cap1.18052wk Low--Dividend TTM94.75MShs Float57.390Historical High--Div YieldTTM5.63%Amplitude0.500Historical Low4.763Avg Price1Lot Size
Applied Therapeutics Stock Forum
See what comes from this? Along with my post from 3/28! LIKE!
Make a note!
The biopharmaceutical company said Thursday that the Food and Drug Administration now has a target action date of Nov. 28 for its application, compared with the previous date of Aug. 28.
The company's application is for govorestat in the treatment of Galactosemia, a rare genetic condition that makes patients unable to metab...
Therapeutics Company Announce FDA Acceptance For New Galactosemia Treatment
In a significant development for the healthcare sector and investors worldwide, Applied Therapeutics Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, has announced the Food and Drug Administration's acceptance and priority review of t...
$APLT Applied Therapeutics Announces $100 Million Private Placement
FDA priority review
Watchlist.
$ZyVersa Therapeutics(ZVSA.US)$$Roma Green Finance(ROMA.US)$$Veru Inc(VERU.US)$$Achilles Therapeutics(ACHL.US)$$Gaxos.ai(GXAI.US)$$Applied Therapeutics(APLT.US)$$Sonder Holdings(SOND.US)$
📊⚡️📊
Ph 3 readouts in Q1 2024...
$Regenxbio(RGNX.US)$ Phase 3
$Annovis Bio(ANVS.US)$ Phase 3
$Atea Pharmaceuticals(AVIR.US)$ Phase 3
$Ironwood Pharmaceuticals(IRWD.US)$ Phase 3
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 3
$Vertex Pharmaceuticals(VRTX.US)$ Phase 3
$KalVista Pharmaceuticals(KALV.US)$ Phase 3
$Axsome Therapeutics(AXSM.US)$ Phase 3
$Novocure(NVCR.US)$ Phase 3
$ROCHE HOLDING AG(RHHBY.US)$ Phase 3
$FibroGen(FGEN.US)$ Phase 3
$Applied Therapeutics(APLT.US)$ Phase 3
$ACADIA Pharmaceuticals(ACAD.US)$ Phase 3...
ColumnsWall Street Today | US Stocks End Weekly Winning Streak
Investors Rethink Rate Cut Bets
US equities ended Friday slightly higher, but gains weren't enough to keep major indices in the green in the first trading week of the year. The stock market ended their nine-week winning streak as investors rethink bets of aggressive interest rate cuts this year amid signs of continued strength in the labor market.
The $S&P 500 Index(.SPX.US)$ rose 0.2% to close at 4,697.24 Friday, while the $Nasdaq Composite Index(.IXIC.US)$ rose less...
No comment yet